Navigation Links
BD LSR II System from BD Biosciences - Immunocytometry Systems

ProductsBD LSR II System from BD Biosciences - Immunocytometry Systems
Company BD Biosciences - Immunocytometry Systems
Item BD LSR II System
Price 
Description Building on the ease of use and flexibility of the BDTM LSR, the first UV benchtop analyzer, BD Biosciences introduces the BDTM LSR II. The BD LSR II has performance, capabilities, and flexibility never seen before in a benchtop analyzer. Free up your high-performance cell sorter by moving your application(s) that require a UV laser to the BD LSR II.

The BD LSR II can be configured with up to four fixed alignment lasers and the ability to detect up to 18 colors, utilizing a revolutionary optical design. The BD LSR II can be configured with a 488 nm, 405 nm, 633 nm, and 355nm UV laser. At the heart of the BD LSR II are new digital electronics. The electronics digitize signals 10 million times per second in 16,384 discrete levels. This expands channel resolution and increases detection sensitivity. Electronic dead time is eliminated; more precise fluorescent measurements can be made improving linearity, compensation, and quantitation of fluorescence measurements.

BD LSR II System

  • Up to 18-color detection
  • Digital acquisition and analysis system
  • Flexible and modular for future upgrades
Laser Options
  • 355nm UV, 405 nm, 633 nm
Info BD Biosciences - Immunocytometry SystemsBD Biosciences - Immunocytometry Systems
2350 Qume Drive
San Jose, CA, 95131-1807

Customer Service: (877) 232-8995
Fax Number: (408) 954-2347
Web Site: http://www.bdbiosciences.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. R.A.P.I.D. System from Idaho Technology Inc.
2. CEQ 8800 Genetic Analysis System from Beckman Coulter
3. ProteomeLab PA 800 Protein Characterization System from Beckman Coulter
4. ProteomeLab PF 2D Protein Fractionation System from Beckman Coulter
5. pET GST Fusion System 42 plus Competent Cells from Novagen
6. pET GST Fusion System 42 from Novagen
7. pET GST Fusion System 41 plus Competent Cells from Novagen
8. pET GST Fusion System 41 from Novagen
9. Mouse Dopaminergic Neuron Differentiation Kit, 2nd Generation from R&D Systems
10. CEQ 8000 Genetic Analysis System from Beckman Coulter
11. LCMS-IT-TOF Formula Predictor System from Shimadzu
Human peripheral blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Umbilical cord blood mononuclear cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Human plasmacytoid dendritic cells, BDCA-4+, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Umbilical cord blood basophils, For immunohistochemistry (IHC)...
Biology Products:
(Date:3/2/2017)... Summary This report provides all the information you ... activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... an in-depth insight into the partnering activity of one of ... company reports are prepared upon purchase to ensure inclusion of ...
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
(Date:2/28/2017)... -- News solutions for biometrics, bag drop and New ... At ... 16 March, Materna will present its complete end-to-end passenger journey, ... a real benefit for passengers. To accelerate the whole passenger ... point solutions to take passengers through the complete integrated process ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)...  BioPharmX Corporation (NYSE MKT: BPMX), a specialty ... today reported financial results for the quarter and ... an update on the company,s clinical development efforts ... are pleased to report that last year was ... Anja Krammer. "We achieved key clinical milestones and ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/23/2017)... , March 23, 2017 ... at four equities in the Biotech industry: Sangamo Therapeutics ... Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. ... st , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology ... downloading their free report at: ...
Breaking Biology Technology: